Literature DB >> 31682854

Oxytocin Exerts Antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC.

Qian Li1, Bing Zhang2, Hang Cao1, Wei Liu1, Fei Guo3, Fuyi Shen1, Binglu Ye1, Huan Liu4, Yang Li5, Zhiqiang Liu6.   

Abstract

Oxytocin (OT) and dopamine (DA) are two important elements that are closely related to mental and reward processes in the brain. OT controlled DA functional regulation contributes to various behaviours such as social reward, social cognition and emotion-related behaviours. Previous studies indicated that diminished dopaminergic transmission in the medial prefrontal cortex (mPFC) is correlated with the pathophysiology of depression. However, the interaction of OT and DA and their roles in antidepressant effects still require further exploration. Here, we investigated the antidepressant effect of OT through local mPFC administration, and further explored the underlying mechanisms that indicated that OT could strengthen dopaminergic synaptic transmission with OT receptor (OTR) activation dependent in the mPFC. Our results showed that local administration of OT in the mPFC exerts antidepressant (-like) effects in both naïve and social defeat stress (SDS) depressive animal model. Mechanism study suggested that OT enhances DA level with OTR activation dependent, and elevated mPFC DA levels might further enhance excitatory synaptic transmission by activating the D1/PKA/DARPP32 intracellular signalling pathway in the mPFC. Hence, our study revealed that the activation of OTR strengthens excitatory synaptic transmission via the potentiation of dopaminergic synaptic transmission, especially via D1R activation dependent, in the mPFC, which may be the underlying mechanism of antidepressant (-like) effects mediated by OT. With specifically activation of the D1/PKA/DAPRR32 signalling pathway, our results may augment the important role of OT in reward circuits in the central nervous system.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Antidepressant effect; Dopamine; Oxytocin; mPFC

Year:  2019        PMID: 31682854     DOI: 10.1016/j.neuropharm.2019.107836

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

Review 1.  Neural circuits regulating prosocial behaviors.

Authors:  Jessica J Walsh; Daniel J Christoffel; Robert C Malenka
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 7.853

2.  Antidepressant-like effects of cinnamamide derivative M2 via D2 receptors in the mouse medial prefrontal cortex.

Authors:  Yan-Xin Che; Xiao-Yan Jin; Rong-Hua Xiao; Ming Zhang; Xiao-Hui Ma; Fei Guo; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2022-01-25       Impact factor: 7.169

3.  New monoamine antidepressant, hypidone hydrochloride (YL-0919), enhances the excitability of medial prefrontal cortex in mice via a neural disinhibition mechanism.

Authors:  Yong-Mei Zhang; Lu-Yu Ye; Tian-Yu Li; Fan Guo; Fei Guo; Yang Li; Yun-Feng Li
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

Review 4.  Oxytocin Signaling as a Target to Block Social Defeat-Induced Increases in Drug Abuse Reward.

Authors:  Carmen Ferrer-Pérez; Marina D Reguilón; José Miñarro; Marta Rodríguez-Arias
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

5.  Stress modulates Ahi1-dependent nuclear localization of ten-eleven translocation protein 2.

Authors:  Qian Zhang; Qicheng Hu; Junjie Wang; Zhigang Miao; Ziyi Li; Yuwen Zhao; Bo Wan; Emily G Allen; Miao Sun; Peng Jin; Xingshun Xu
Journal:  Hum Mol Genet       Date:  2021-11-01       Impact factor: 5.121

Review 6.  Is Oxytocin "Nature's Medicine"?

Authors:  C Sue Carter; William M Kenkel; Evan L MacLean; Steven R Wilson; Allison M Perkeybile; Jason R Yee; Craig F Ferris; Hossein P Nazarloo; Stephen W Porges; John M Davis; Jessica J Connelly; Marcy A Kingsbury
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.